The Science of Eye Movements

Learn more about how we have pioneered the understanding of abnormal eye movements for concussions, ADHD, fatigue and more

31 NeuroSync Publications
16 NeuroSync Patents
403 Related Publications

Literature References

Eye Movement Abnormalities Across the Lifespan

Abnormal eye movements can serve as biomarkers for various neurological conditions, disease, and pathology. From early development when our attention matures, to early and later adulthood when we may experience injuries, to early aging when the first signs of disease may become apparent. Tracking eye movements provides high fidelity insight into cognition, that cannot be replicated by direct observation. Capturing these eye movements can provide the indication of the specific condition, mark the progression of disease, or signify the resolution of injury.


image description
Time Continuum



Abnormal gaze holding Therapy, visual training



Eye Velocity Instability Therapy, visual training



Abnormal jerking, nystagmus Therapy, visual training

Sleep Deprivation/Fatigue


Increased Spatial Gaze Errors Targeted recovery, activity modification

Parkinson’s Disease


Predictive Gaze Errors Therapy, medication


Predcitive Gaze Errors Therapy, medication

The content provided is an educational resource only and does not specifically refer to EYE-SYNC product features.

SyncThink Patents

  1. US 16/525,425 – Granted 7/29/19
    System and method for dynamic content delivery based on gaze analytics
  2. US 15/967,440 – Granted 6/28/19
    System and method for dynamic content delivery based on gaze analytics
  3. EP 3,032,998 – Granted 3/20/19
    System for cognition and ocularmotor impairment diagnosis using binocular coordination analysis
  4. US 14/530,598 – Granted 1/10/18
    System and method for dynamic content delivery based on gaze analytics
  5. US 9/439,952 – Granted 9/13/16
    Eye tracking headset and system for neuropsychological testing including the detection of brain damage
  6. EP 9,265,458 – Granted 2/23/16
    Application of smooth pursuit cognitive testing paradigms to clinical drug development
  7. EP 1,942,803 – Granted 10/14/15
    Cognition and motor timing diagnosis using smooth eye pursuit analysis